Leadership & Management
Sanofi ANZ appoints Liz Selby as Country Lead after serving as acting leader
Leadership & Management: Sanofi has appointed Liz Selby as the Country Lead and Head of Pharma ANZ, with immediate effect. This decision places Selby in a permanent role, overseeing the company’s core operations and strategic growth across Australia and New Zealand.
In recent months, Selby has navigated the local team through a period of significant modernization as the company prepares for its future in immunology leadership. Alongside this transformation, she has adeptly managed the essential day-to-day operations that support Sanofi’s commitment to customers, patients, and employees.
This leadership transition came as Karen Hood stepped down from her role as Country Lead. Additionally, Rebekah Cassidy, Sanofi’s Deputy Head of Corporate Affairs and Sustainability for ANZ, took on the role as CEO of AusBiotech.
Selby leads the recently integrated Pharma business unit, overseeing key portfolios such as Immunology, Diabetes, Rare Disease, Rare Blood Disorders, and Virtual Healthcare. She is also responsible for Sanofi’s local operations, including Trade, Market Access, and Corporate Affairs, bringing a broad scope to her mandate.
Reflecting on Sanofi’s strategic direction, Selby stated, “The next chapter of Sanofi’s Play to Win Strategy will challenge us to take steps that optimize the way we work, accelerate innovation, and deepen our investment in R&D as we evolve into a company powered by AI. The team in Australia & New Zealand never settles, and we’re ready to keep delivering.”
Selby’s career began as a frontline health worker, and her extensive experience in the healthcare industry complements her business acumen. Prior to her Country Lead role, Selby’s led the Sanofi team as General Manager of the Specialty Care division. Known for her sense of purpose and drive for continuous improvement, she strives to inspire others through her approach to leadership and development.
In addition to senior leadership responsibilities, Selby is committed to inclusivity as an Ally and Sponsor of Sanofi’s Pride+ community. She has also taken on the role of Sponsor for the Gender+ community, further supporting diversity and representation within the organisation.
In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - Pharmaceuticals
Federal Health Minister succumbs to pressure, commits to extra meeting to clear PBAC backlog
Pharma News: The Minister for Health and Aged Care, Mark Butler MP, has confirmed that the Pharmaceutical Benefits Advisory Committee […]
MoreNews & Trends - MedTech & Diagnostics
Medtech company partners with Aussie researchers in AI technology for GI cancer detection
MedTech & Diagnostics News: To develop a next-generation gastrointestinal (GI) flexible endomicroscope equipped with edge-artificial intelligence (AI) technology, Monash University’s […]
MoreNews & Trends - Pharmaceuticals
Local oncologists first to enrol prostate cancer patients in phase 3 theranostics trial
Pharma News: GenesisCare oncologists have achieved a significant milestone, becoming the first to enrol and deliver patient treatment in a […]
MoreHuman Resources
Ipsen’s culture of ‘collaboration and diversity’ earns Great Place to Work certification
Ipsen Australia and New Zealand has announced its certification as a Great Place to Work in 2024, joining 11 other […]
More